Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Academic Article
Publication Date:
2011
Short description:
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial / Viale G, 1.7.7., Regan, M.m., Dell’Orto, P., Mastropasqua, M.g., Maiorano, E., Rasmussen, B.b., Macgrogan, G., Forbes, J.f., Paridaens, R.j., Colleoni, M., Làng, I., Thurlimann, ., Mouridsen, H., Mauriac, L., Gelber, R.d., Price, K.n., Goldhirsch, A., Gusterson, B.a., Coates, A.s.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 22:10(2011), pp. 2201-2207. [10.1093/annonc/mdq738]
Iris type:
1.1 Articolo in rivista
Keywords:
Breast cancer; Therapy; clinical trial
List of contributors:
Viale G, 1. 7. 7.; Regan, Mm; Dell’Orto, P; Mastropasqua, Mg; Maiorano, Eugenio; Rasmussen, Bb; Macgrogan, G; Forbes, Jf; Paridaens, Rj; Colleoni, M; Làng, I; Thurlimann, ; Mouridsen, H; Mauriac, L; Gelber, Rd; Price, Kn; Goldhirsch, A; Gusterson, Ba; Coates, As
Published in: